Deficiency of alpha-dystroglycan in muscle-eye-brain disease.

Journal: Biochemical And Biophysical Research Communications
Published:
Abstract

Alpha-dystroglycan is a component of the dystrophin-glycoprotein-complex, which is the major mechanism of attachment between the cytoskeleton and the extracellular matrix. Muscle-eye-brain disease (MEB) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities and lissencephaly. We recently found that MEB is caused by mutations in the protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1) gene. POMGnT1 is a glycosylation enzyme that participates in the synthesis of O-mannosyl glycan, a modification that is rare in mammals but is known to be a laminin-binding ligand of alpha-dystroglycan. Here we report a selective deficiency of alpha-dystroglycan in MEB patients. This finding suggests that alpha-dystroglycan is a potential target of POMGnT1 and that altered glycosylation of alpha-dystroglycan may play a critical role in the pathomechanism of MEB and some forms of muscular dystrophy.

Authors
Hiroki Kano, Kazuhiro Kobayashi, Ralf Herrmann, Masaji Tachikawa, Hiroshi Manya, Ichizo Nishino, Ikuya Nonaka, Volker Straub, Beril Talim, Thomas Voit, Haluk Topaloglu, Tamao Endo, Hideki Yoshikawa, Tatsushi Toda
Relevant Conditions

Nearsightedness